Screener
Rapport Therapeutics, Inc. RAPP Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $2,796 | $4,190 |
| Accrued expenses and other current liabilities | 23,155 | 12,104 |
| Operating lease liability | 2,473 | 2,755 |
| Total current liabilities | 28,424 | 19,049 |
| Operating lease liability, net of current portion | 7,632 | 8,729 |
| Total liabilities | 36,056 | 27,778 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s total current liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported total current liabilities of $28.42M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s total current liabilities increased by 139.3% year-over-year, from $11.88M to $28.42M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total current liabilities?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total current liabilities has grown at a 47.1% compound annual growth rate (CAGR), from $8.8M to $19.05M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Rapport Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude